A
Alan M. Garber
Researcher at Harvard University
Publications - 298
Citations - 16901
Alan M. Garber is an academic researcher from Harvard University. The author has contributed to research in topics: Health care & Cost effectiveness. The author has an hindex of 69, co-authored 298 publications receiving 16297 citations. Previous affiliations of Alan M. Garber include VA Palo Alto Healthcare System & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.
Alan M. Garber,Robert R. Henry,Robert E. Ratner,Pedro A Garcia-Hernandez,Hiromi Rodriguez-Pattzi,Israel Olvera-Alvarez,Paula M Hale,Milan Zdravkovic,Bruce W. Bode +8 more
TL;DR: Liraglutide is safe and effective as initial pharmacological therapy for type 2 diabetes mellitus and leads to greater reductions in HbA(1c), weight, hypoglycaemia, and blood pressure than does glimepiride.
Journal ArticleDOI
Economic Foundations of Cost-Effectiveness Analysis
TL;DR: It is shown how a cost-effectiveness criterion can be derived to guide resource allocation decisions, and how it varies with age, gender, income level, and risk aversion.
Journal ArticleDOI
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
TL;DR: In this article, the authors compared the safety and efficacy of low-molecular-weight heparins with those of unfractionated heparin for treatment of acute deep venous thrombosis.
Journal ArticleDOI
Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
Philip Raskin,Elsie Allen,Priscilla Hollander,Andrew Lewin,Robert A. Gabbay,Peter Hu,Bruce W. Bode,Alan M. Garber +7 more
TL;DR: In subjects with type 2 diabetes poorly controlled on OADs, initiating insulin therapy with twice-daily BIAsp 70/30 was more effective in achieving HbA(1c) targets than once-daily glargine, especially in subjects with Hb a( 1c) >8.5%.
Journal ArticleDOI
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
Y Handelsman,Jeffrey I. Mechanick,Lawrence Blonde,George Grunberger,Zachary T. Bloomgarden,George A. Bray,Samuel Dagogo-Jack,Jaime A. Davidson,Daniel Einhorn,Om P. Ganda,Alan M. Garber,Irl B. Hirsch,Edward S. Horton,Faramarz Ismail-Beigi,Paul S. Jellinger,Kenneth L. Jones,Lois Jovanovic,Harold E. Lebovitz,Philip T. Levy,Etie S. Moghissi,Eric A. Orzeck,Aaron I. Vinik,Kathleen Wyne +22 more